Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Press Releases
Donate Now
MJFF in the News

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

 From
To
  • Default content image

    Michael J. Fox Foundation for Parkinson’s Research to Host PD Therapeutics Conference Monday, September 15, in Chicago

    What:                     The Michael J. Fox Foundation PD Therapeutics ConferenceWhen: …
    Learn more
  • Default content image

    Michael J. Fox Foundation Funds $1.1 Million For Cutting-Edge Approaches To Parkinson's Disease Under Rapid Response Innovation Awards 2008

    NEW YORK, NY — Gene silencing techniques and induced pluripotent stem cell technology are among the cutting-edge approaches to Parkinson’s drug development funded through The Michael J. Fox…
    Learn more
  • Default content image

    Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics

    NEW YORK, NY — As part of its mission to speed delivery of transformative treatments and a cure for Parkinson’s disease, The Michael J. Fox Foundation for Parkinson’s Research has awarded $2.7…
    Learn more
  • Default content image

    Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinson's Disease

    NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research today announced approximately $2.4 million in total funding to nine research teams under its Target Validation initiative. This…
    Learn more
  • Default content image

    Michael J. Fox Foundation for Parkinson’s Research Commits up to $2 Million to Visualize Alpha-Synuclein Protein in the Brain

    NEWYORK, NY—The Michael J. Fox Foundation for Parkinson’s Research is committing up to $2 million to develop and test non-invasive imaging technologies that would allow scientists to visualize…
    Learn more
  • Default content image

    Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine

    NEWYORK, NY — The Michael J. Fox Foundation announced a $5.6-million award to drive a Phase 2 clinical trial to investigate the potential of inosine — a naturally occurring chemical that gives rise…
    Learn more
  • Default content image

    Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative

    NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research seeks applications from industry and academic researchers for its $10-million 2008 Therapeutics Development Initiative (TDI). The…
    Learn more
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.